These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 29605770)

  • 1. p-Coumaric acid mediated protection of H9c2 cells from Doxorubicin-induced cardiotoxicity: Involvement of augmented Nrf2 and autophagy.
    Sunitha MC; Dhanyakrishnan R; PrakashKumar B; Nevin KG
    Biomed Pharmacother; 2018 Jun; 102():823-832. PubMed ID: 29605770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Ganoderma lucidum polysaccharides against doxorubicin-induced cardiotoxicity.
    Xu F; Li X; Xiao X; Liu LF; Zhang L; Lin PP; Zhang SL; Li QS
    Biomed Pharmacother; 2017 Nov; 95():504-512. PubMed ID: 28866417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
    Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
    Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAY60-2770 attenuates doxorubicin-induced cardiotoxicity by decreased oxidative stress and enhanced autophagy.
    Zhao XX; Cho H; Lee S; Woo JS; Song MY; Cheng XW; Lee KH; Kim W
    Chem Biol Interact; 2020 Sep; 328():109190. PubMed ID: 32652078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Punicalagin protects H9c2 cardiomyocytes from doxorubicin-induced toxicity through activation of Nrf2/HO-1 signaling.
    Ye M; Zhang L; Yan Y; Lin H
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lotusine, an alkaloid from Nelumbo nucifera (Gaertn.), attenuates doxorubicin-induced toxicity in embryonically derived H9c2 cells.
    Harishkumar R; Selvaraj CI
    In Vitro Cell Dev Biol Anim; 2020 May; 56(5):367-377. PubMed ID: 32468412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells.
    Dallons M; Alpan E; Schepkens C; Tagliatti V; Colet JM
    Cells; 2020 Sep; 9(10):. PubMed ID: 32992522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycyrrhiza glabra (Licorice) root extract attenuates doxorubicin-induced cardiotoxicity via alleviating oxidative stress and stabilising the cardiac health in H9c2 cardiomyocytes.
    Upadhyay S; Mantha AK; Dhiman M
    J Ethnopharmacol; 2020 Aug; 258():112690. PubMed ID: 32105749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2.
    Zhao L; Qi Y; Xu L; Tao X; Han X; Yin L; Peng J
    Redox Biol; 2018 May; 15():284-296. PubMed ID: 29304479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling.
    Qi W; Boliang W; Xiaoxi T; Guoqiang F; Jianbo X; Gang W
    Biomed Pharmacother; 2020 Feb; 122():109547. PubMed ID: 31918264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity.
    Gu J; Hu W; Song ZP; Chen YG; Zhang DD; Wang CQ
    Int Immunopharmacol; 2016 Mar; 32():1-7. PubMed ID: 26774212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan oligosaccharides prevent doxorubicin-induced oxidative stress and cardiac apoptosis through activating p38 and JNK MAPK mediated Nrf2/ARE pathway.
    Zhang Y; Ahmad KA; Khan FU; Yan S; Ihsan AU; Ding Q
    Chem Biol Interact; 2019 May; 305():54-65. PubMed ID: 30928397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-ascorbic acid and α-tocopherol attenuate arsenic trioxide-induced toxicity in H9c2 cardiomyocytes by the activation of Nrf2 and Bcl2 transcription factors.
    Vineetha RC; Binu P; Arathi P; Nair RH
    Toxicol Mech Methods; 2018 Jun; 28(5):353-360. PubMed ID: 29297235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neferine modulates IGF-1R/Nrf2 signaling in doxorubicin treated H9c2 cardiomyoblasts.
    Bharathi Priya L; Baskaran R; Huang CY; Vijaya Padma V
    J Cell Biochem; 2018 Feb; 119(2):1441-1452. PubMed ID: 28731223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of treatment governs curcumin response on doxorubicin-induced toxicity in cardiomyoblasts.
    Jain A; Rani V
    Mol Cell Biochem; 2018 May; 442(1-2):81-96. PubMed ID: 28929270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of
    Chacko SM; Nevin KG; Dhanyakrishnan R; Kumar BP
    Toxicol Rep; 2015; 2():1213-1221. PubMed ID: 28962464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
    Zhang QL; Yang JJ; Zhang HS
    Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yellow Wine Polyphenolic Compounds prevents Doxorubicin-induced cardiotoxicity through activation of the Nrf2 signalling pathway.
    Lin H; Zhang J; Ni T; Lin N; Meng L; Gao F; Luo H; Liu X; Chi J; Guo H
    J Cell Mol Med; 2019 Sep; 23(9):6034-6047. PubMed ID: 31225944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.